The import of pharmaceutical goods to Angola saw significant fluctuations from 2013 to 2023. In 2013, the imports stood at $5.0038 million, decreasing by 25.03% from the previous year. There was a sharp increase of 90.07% in 2014, but a significant drop of 57.39% followed in 2015. The subsequent years saw varying trends, with another notable increase in 2017 of 56.31%. However, from 2018 onwards, a gradual decline set in, culminating in a value of $4.5125 million in 2023. The average compound annual growth rate over the last 5 years has been -1.78%.
The forecasted data suggests a continuation of this downward trend, with projected imports decreasing to $4.0936 million by 2028. The 5-year compounded annual growth rate from 2024 to 2028 is expected to be -1.63%, indicating a 7.87% reduction in pharmaceutical imports over this period.
Future trends to watch for:
- Impact of economic policies and healthcare reforms in Angola on pharmaceutical imports.
- Changes in global pharmaceutical supply chains and how they might affect Angola.
- Potential growth in local pharmaceutical manufacturing reducing dependency on imports.
